Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience

PURPOSE: To evaluate the outcome of glaucoma drainage device (GDD) implantation with and without intravitreal bevacizumab (IVB) injection in treating neovascular glaucoma (NVG) at Cipto Mangunkusumo Hospital Jakarta, Indonesia. PATIENTS AND METHODS: This retrospective study involved 39 eyes with NVG...

Descripción completa

Detalles Bibliográficos
Autores principales: Noor, Nina Asrini, Mustafa, Syukri, Artini, Widya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557098/
https://www.ncbi.nlm.nih.gov/pubmed/28848323
http://dx.doi.org/10.2147/OPTH.S137470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557098/
https://www.ncbi.nlm.nih.gov/pubmed/28848323
http://dx.doi.org/10.2147/OPTH.S137470

Ejemplares similares